Old antihypertensive agents-diuretics and β-blockers: Do we know how and in whom they lower blood pressure?

Current Hypertension Reports

Volumn 1, Issue 4, 1999, Pages 296-304

  Sica, Domenic A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BENZOTHIADIAZINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

BLOOD PRESSURE; DRUG EFFECT; HEART OUTPUT; HUMAN; REVIEW; VASCULAR RESISTANCE;

ADRENERGIC BETA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; BENZOTHIADIAZINES; BLOOD PRESSURE; CARDIAC OUTPUT; DIURETICS; HUMANS; SODIUM CHLORIDE SYMPORTER INHIBITORS; VASCULAR RESISTANCE;

EID: 0033170543     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-999-0037-2     Document Type: Article

References (57)

1. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: a cooperative study. JAMA 1977, 237: 255-261.
2. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The 1980 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1980, 140: 1280-1285.
3. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure; The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1984, 144: 1045-1057.
4. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The fourth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988, 148: 1023-1038.
5. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993, 153: 154-183.
6. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Ann Intern Med 1997, 157: 2413-2446.
7. Philipp T, Anlauf M, Distler A, et al.: Randomised, doubleblind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in hypertensive treatment: results of the HANE study: HANE Trial Research Group. BMJ 1997, 315: 154-159.
8. Hansson L, Lindholm LH, Niskanen L, et al.: Effect of angiotensin converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Projec (CAPP) randomised trial. Lancet 1999, 353: 611-616.
9. Systolic Hypertension in the Elderly Program Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265: 3255-3264.
10. Pahor M, Shorr RI, Somes GW, et al.: Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the Systolic Hypertension in the Elderly Program. Arch Intern Med 1998, 158: 1340-1345.
11. Curb JD, Pressel SL, Cutler JA, et al.: Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996, 276: 1886-1892.
12. Kostis JB, Davis BR, Cutler J, et al.: Prevention of heart failure by antihypertensive drug treatment in older patients with isolated systolic hypertension. JAMA 1997, 278: 212-216.
13. Manolio TA, Cutler JA, Furberg CD, et al.: Trends in pharmacologic management of hypertension in the United States. Arch Intern Med 1995, 155: 829-837.
14. Siegel D, Lopez J, Meier J: Pharmacologic treatment of hypertension in the Department of Veterans Affairs during 1995 and 1996. Am J Hypertens 1998, 11: 1271-1278.
15. Psaty BM, Koepsell TD, Yanez D, et al.: Temporal patterns of antihypertensive medication use among older adults, 1989 through 1992. JAMA 1995, 273: 1436-1438.
16. Caro JJ, Speckman JL, Salas M, et al.: Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. Can Med Assoc J 1999, 160: 41-46.
17. Dustan H, Roccella EJ, Garrison HH: Controlling hypertension. A research success story. Arch Intern Med 1996, 156: 1926-1935.
18. Roos JC, Boer P, Koomans HA, et al.: Haemodynamic and hormonal changes during acute and chronic diuretic treatment in essential hypertension. Eur J Clin Pharmacol 1981, 19: 107-122.
19. Van Brummelen P, Man in't Veld AL, Schalekamp MADH: Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and non-responders. Clin Pharmacol Ther 1980, 27: 328-336.
20. Tarazi RC, Dustan HP, Frohlich ED: Long-term thiazide therapy in essential hypertension. Circulation 1970, 41: 709-717.
21. Conway J, Lauwers P: Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide. Circulation 1960, 21: 21-26.
22. Shah S, Khatri I, Freis ED: Mechanism of antihypertensive effect of thiazide diuretics. Am Heart J 1978, 95: 611-618.
23. Bennett WM, McDonald WJ, Kuehnel E, et al.: Do diuretics have antihypertensive properties independent of natriuresis? Clin Pharmacol Ther 1977, 22: 499-504.
24. Kelly DA, Hamilton S: A placebo-controlled trial to evaluate the antihypertensive efficacy and acceptability of indapamide. Curr Med Res Opin 1977, 5: 137-144.
25. Hollan OB, Gomez-Sanchez CE, Kuhnert LV, et al.: Antihypertensive comparison of furosemide with hydrochlorothiazide for black patients. Arch Intern Med 1979, 139: 1015-1021.
26. Sica DA, Gehr TWB: Diuretic combination in refractory edema states: pharmacokinetic and pharmacodynamic relationships. Clin Pharmacokinet 1996, 30: 229-249.
27. Dunn CJ, Fitton A, Brogden RN: Torasemide. An update of its pharmacological properties and therapeutic efficacy. Drugs 1995, 49: 121-142.
28. Neaton JD, Grimm RH Jr, Prineas RJ, et al.: Treatment of mild hypertension study (TOMHS): final results. JAMA 1993, 270: 713-724.
29. Materson BJ, Reda DJ, Cushman WC, et al.: Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 1993, 328: 914-921.
30. Messerli FH, Grossman E, Goldbourt U: Are b-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA 1998; 279: 1903-1907.
31. Sica DA: Fixed-dose combination therapy. Is it rational? Drugs 1994, 48: 16-24.
32. Hansson L, Zanchetti A, Carruthers SG, et al.: Effect of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998, 351: 1755-1762.
33. Flack JM, Cushman WC: Evidence for the efficacy of low-dose diuretic monotherapy. Am J Med 1996, 101:53S-60S.
34. Moser M: Why are physicians not prescribing diuretics more frequently in the management of hypertension? JAMA 1998, 270: 1813-1816.
35. Fitzgerald JD: Introduction to focused section on new developments in b-blockade. Cardiovasc Drugs Ther 1991, 5: 544-548.
36. Soriano JB, Hoes AW, Meems L, et al.: Increased survival with b-blockers: importance of ancillary properties. Prog Cardiovasc Dis 1997, 39: 445-456.
37. Man in't Veld AJ, van den Meiracker AH, Schalekamp MA: Do b-blockers really increase peripheral vascular resistance? Am J Hypertens 1988, 1: 91-96.
38. Frohlich ED, Tarazi RC, Dustan HP, et al.: The paradox of b-adrenergic blockade in hypertension. Circulation 1968, 37: 417-423.
39. Fouad FM, Slominski MJ, Tarazi RC, et al.: Alternation in left ventricular filling with b-adrenergic blockade. Am J Cardiol 1983, 51: 161-164.
40. Colfer HT, Cottier C, Sanchez R, et al.: Role of cardiac factors in the initial hypotensive action by b-adrenoreceptor blocking agents. Hypertension 1984, 6: 145-151.
41. Blumenfeld JD, Sealey JE, Bragat AC, et al.: Effects of b-blockade on blood pressure, prorenin, renin, and angiotensin II and its interaction with captopril in normotensives and essential hypertensives. J Am Soc Nephrol 1995, 6:638.
42. Laragh JH: Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med 1973, 55: 261-274.
43. DeLeeuw PW, Birkenhager WH: Renal response to propranolol treatment in hypertensive humans. Hypertension 1982, 4: 125-131.
44. Castenfors J, Johnsson H, Oro L: Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients. Acta Med Scand 1973, 193: 189-195.
45. Rosen SG, Supiano MA, Perry TJ, et al.: B-adrenergic blockade decreases norepinephrine release in humans Am J Physiol 1990, 258:E999-E1005.
46. Esler M, Jackman G, Leonard P, et al.: Effect of propranolol on noradrenaline kinetics in patients with essential hypertension. Br J Clin Pharmacol 1981, 12: 374-380.
47. Saunders E, Weir M, Kong BW, et al.: A comparison of the efficacy and safety of a b-blocker, a calcium-channel blocker and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med 1990, 150: 1707-1713.
48. Serlin MJ, Orme ML'E, Baber NS, et al.: Propranolol in the control of blood pressure: a dose-response study. Clin Pharmacol Ther 1980, 27: 586-592.
49. Marshall AJ, Barritt DW, Heaton S, et al.: Dose response for blood pressure and degree of cardiac b-blockade with atenolol. Postgrad Med J 1979, 55: 537-540.
50. Raftery EB, Carrageta MO: Hypertension and b-blockers. Are they all the same? Int J Cardiol 1985, 7: 337-346.
51. Sica DA: Cardiopulmonary effects of ophthalmically administered b-blockers. Cong Heart Failure 1999, 5: 81-85.
52. McAinsh J, Holmes BF, Smith S, et al.: Atenolol kinetics in renal failure. Clin Pharmacol Ther 1980, 28: 302-309.
53. Grimm RH, Grandits JA, Cutler JA, et al.: Relationship of quality of life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med 1997, 157: 638-648.
54. Paran E, Anson O, Neumann L: The effects of replacing b-blockers with an angiotensin converting enzyme inhibitor on the quality of life in hypertensive patients. Am J Hypertens 1996, 9: 1206-1213.
55. Krumholz HM, Radford MJ, Wang Y, et al.: National use and effectiveness of b-blockers for the treatment of elderly patients after acute myocardial infarction. J Am Med Assoc 1998, 280: 623-629.
56. Avezum A, Tsuyuki T, Pogue J, et al.: B-blocker therapy for congestive heart failure: a systematic overview and critical appraisal of the published trials. Can J Cardiol 1998, 14: 1045-1053.
57. IMS America Ltd.: National Prescription Audit.Ambler, PA: IMS America Ltd.; 1997.